Testing AMH as an indicator of ovarian response in assisted reproductive technologies

Volume 20 No 7 (2022)

Suchitra Narayan,Purnima Pachori,Sandhya Choudhry,Mahima Agrawal,

DOI: 10.14704/nq.2022.20.7.NQ33350

Abstract

Objective: To evaluate the AMH as a predictive marker of ovarian response in assisted reproductive technology outcome. Methods: 140 women (age 25–40 years) selected for in vitro fertilization treatment were included in this study. Analysis of day-2 serum samples was done for the AMH, FSH, Inhibin B, and LH by ELISA kit methods. USG was done for the antral follicle count (AFC) and oocytes’retrieval

Keywords

Anti-Mullerian hormone, Antral follicle count, Oocytes retrieval count, assisted reproductive technology (ART)

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.